Download Free Prescription Drugs Oxycontin Abuse And Diversion And Efforts To Address The Problem Report To Congressional Requesters Book in PDF and EPUB Free Download. You can read online Prescription Drugs Oxycontin Abuse And Diversion And Efforts To Address The Problem Report To Congressional Requesters and write the review.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
An obsessive true crime investigation of a bizarre and unlikely perpetrator, who’s serving the opioid epidemic’s longest term for illegal prescriptions — four life sentences Written in the tradition of I'll Be Gone in the Dark and True Crime Addict, combining Dopesick's heart rending portrayal of the epidemic's victims with Empire of Pain's examination of its perpetrators This haunting and propulsive debut follows a journalist’s years-long investigation into his father's old classmate: former high school valedictorian Paul Volkman, who once seemed destined for greatness after earning his MD and his PhD from the prestigious University of Chicago, but is now serving four consecutive life sentences at a federal prison in Arizona. Volkman was the central figure in a massive “pill mill” scheme in southern Ohio. His pain clinics accepted only cash, employed armed guards, and dispensed a torrent of opioid painkillers and other controlled substances. For nearly three years, Volkman remained in business despite raids by law enforcement and complaints from patients’ family members. Prosecutors would ultimately link him to the overdose deaths of 13 patients, though investigators explored his ties to at least 20 other deaths. This groundbreaking book is based on 12 years of correspondence and interviews with Volkman. Eil also traveled to 19 states, interviewed more than 150 people, and filed a Freedom of Information Act lawsuit against the Drug Enforcement Administration that led to the release of nearly 20,000 pages of trial evidence. The American opioid epidemic is, like this book, a true crime story. Through this one doctor’s story, an era of unfathomable tragedy is brought down to a tangible, and devastating, human scale.
The definitive book about the impact of prescription painkiller abuse on individuals, communities, and society by one of America's leading experts on addiction. In recent years, the media has inundated us with coverage of the increasing abuse of prescription painkillers. Prescription Painkillers, the third book in Hazelden's Library of Addictive Drugs series, offers current, comprehensive information on the history, social impact, pharmacology, and addiction treatment for commonly abused, highly addictive opiate prescription painkillers such as Oxycontin®, Vicodin, Percocet, and Darvocet. Marvin D. Seppala, MD, provides context for understanding the current drug abuse problem by tracing the history of opioids and the varying patterns of use over time. He then offers an in-depth study of controversial issues surrounding these readily available drugs, including over-prescription by physicians and adolescent abuse. Also included is a straightforward look at the leading treatment protocols based on current research.
"Opioids and Population Health: A Primer, will help senior undergraduate and graduate students to: 1. Describe theories of addiction. 2. Demonstrate the differences between substance abuse prevention, intervention, and treatment. 3. Explain the United States' historical response to opioids. 4. Discuss the differential scope and burden of the current opioid and heroin epidemic on communities and populations. 5. Explain the various sectors, government agencies, and institutions that address addiction generally and the opioid/heroin epidemic specifically. 6. Describe the effectiveness of policy, legal, and regulatory approaches currently in use to address the epidemic. 7. Consider recommendations for sustainable policy and systems changes that are needed to change the opioid addiction trajectory and reduce the epidemic. The text is written through an interdisciplinary approach using the fields of public health, addiction health services research, and implementation science. The authors' experiences with direct client services, city, county, and state governments, managing non-profits, and evaluating treatment interventions speaks to their ability to address issues related to the epidemic thoroughly and critically"--
Part of the Population Health Primer Series, Opioids and Population Health: A Primer provides a concise overview of the opioid crisis leading the reader to explore what's been done to address this epidemic thusfar and what might be done more effectively using a population health approach. Written from a systems and public health perspective, Opioids and Population Health: A Primer begins with an overview of how drug use and addiction have been perceived and how prevention, intervention, and treatment services have been delivered in the U.S. It then reviews the epidemiology of opioid morbidity and mortality, historical framing of addiction, and addresses the government response to the epidemic. Finally, it explores the public health response to the epidemic and considers how a population health approach may better address the epidemic.

To Do No Harm

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources

Published: 2004

Total Pages: 352


Get eBook

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Tens of millions of people around the world live with chronic pain - many in such severe pain they are disabled by it. The Institute of Medicine estimates that chronic pain costs the U.S. alone $560 to $635 billion a year in direct medical costs and lost productivity. Morphine, an effective painkiller, costs only three cents a dose, yet because of excessive regulation in many countries, it is unavailable to millions of people who need it, even at the end of life. The World Health Organization notes that in addition to the one million end-stage AIDS/HIV patients who can't get morphine and other controlled medications, 5.5 million terminal cancer patients, nearly a million people suffering from accidents or violence, and an incalculable number of people living with chronic illnesses or recovering from surgery don't have access to it, either. Furthermore, women, children, older people, and the poor are disproportionally affected by inadequate pain relief. Physicians know almost nothing about chronic pain, much less how to treat it, for two reasons: medical schools barely teach it and government institutions allot almost nothing to the pain research budget. In The Global Pain Crisis: What Everyone Needs to Know®, renowned health journalist Judy Foreman addresses the most important questions about chronic pain: what is it, whom does it affect most, which pain relief methods in Western and alternative medicine are effective, what are the risks and benefits for opioids and marijuana, and how can the chronic pain crisis be resolved for good? Foreman's book is a wake-up call for a health problem that affects people across the globe, from all walks of life. Written in the classic, easy-to-read and quick reference style of the What Everyone Needs to Know® series, The Global Pain Crisis is a must-read for anyone whose life or work is affected by chronic pain.
Transactional to Transformational Marketing in Pharma: The Science of Why and the Art of How is a ground breaking book that explores the current state of the pharmaceutical industry's marketing practices and how they can be improved. Despite being instrumental in saving countless lives and improving the health of people worldwide for over a century, the modern pharmaceutical industry has suffered from a tarnished reputation due to unethical business practices and transactional marketing. In this timely and informative book, the author delves into the reasons behind pharma's fall from grace and shows how transactional marketing practices cannot build brand loyalty or reputation. Instead, the book highlights the importance of transformational marketing practices and ethical business behavior, which can lead to long-term success and customer loyalty. Using real-world examples and case studies, Transactional to Transformational Marketing presents a step-by-step approach to help pharma companies transform their marketing practices. From understanding the importance of customer-centricity to leveraging digital technologies, this book provides practical tips and strategies that can be implemented immediately. Transactional to Transformational Marketing in Pharma is a must-read for anyone interested in elevating the pharmaceutical industry's reputation and creating sustainable growth in the long term. If you are a marketer, business leader, or anyone interested in transforming the pharmaceutical industry's marketing practices, this book is for you.Contents: 1. Pharma’s Reputation on a Slide 2. Ethics in the Pharmaceutical Industry 3. Unethical Marketing Practices in Pharma 4. Transactional Marketing 5. Restoring Pharma’s Reputation 6. Transformational Marketing in Pharma 7. Transformational Marketing in Pharma: Two Case Studies 8. Transformational Marketing the Winner’s Checklist Two Case Studies